MeSH tree: C12.900
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But radical prostatectomy—surgery to remove the prostate—can lead to sexual and physical dysfunction, fatigue, ...
May 11, 2026
0
3
Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study ...
May 3, 2026
0
6
A new scoping review from the University of Toronto reveals that caregivers of loved ones with ovarian cancer face significant emotional strain, heavy caregiving responsibilities, and limited support throughout the disease ...
Apr 30, 2026
0
3
Scientists have uncovered an unexpected way cells can generate cancer-driving proteins—by cutting RNA into shorter, functional fragments rather than following the standard blueprint. This process, newly termed as "RNA dicing," ...
Apr 28, 2026
0
13
The risk of developing a subsequent primary cancer varied significantly by age at initial diagnosis, sex, and type of first cancer, according to a study by Oxana Palesh and Susan Hong and colleagues at Virginia Commonwealth ...
Apr 28, 2026
0
11
Researchers at the University of British Columbia and BC Cancer have developed a new way to target proteins long considered "undruggable," opening the door to new treatments for prostate cancer and other serious diseases. ...
Apr 27, 2026
0
24
Older men with prostate cancer who receive federal housing assistance at the time they are first diagnosed have better two-year survival chances compared to demographically and clinically similar men without that assistance, ...
Apr 21, 2026
0
2
When doctors review diagnostic medical scans for lung cancer, they sometimes spot abnormalities unrelated to the lungs. New research shows that some of those abnormalities could be signs of other undiagnosed cancers. The ...
Mar 31, 2026
0
12
Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in comprehensive genomic profiling ...
Mar 31, 2026
0
4
The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.
Mar 29, 2026
0
4
